NHS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)

Contract summary

Industry

• Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£431,955,441

Procurement reference

CF-0346100D0O000000rwimUAA1

Published date

15 September 2021

Closing date

20 October 2021

Closing time

1pm

Contract start date

1 March 2022

Contract end date

29 February 2024

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

---

Description

Offer reference number: CM/PHR/20/5600
CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

---

More information

Links

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUY3/0pVTiTy4n.zpTieS2dMjPDaowLrLXhLUZIYVkh87yWw
• Document No. 01 - Invitation to offer covering letter (A2486901)#3

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUZ7/GRRlVDKtY.XCEBD_cTr9NYU_q8ARrINjyuOkSIt5VaY
• Document No. 02 - Terms of offer

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYt/EoHjs3hsRXgsD8IG8YYpur3AOYPDJa0d.nwhHTuFSIk
• Document No. 04 - Contract technical specification (A2383497)

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYZ/TQyOcVDsBlnjfPU2kSA_n7b5DY8gs0RcFJp9tGp88ww
• Document No. 07a - Quality control technical sheet (A2383499)

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUZB/fNKIaCtQbpwBhv39YQJaZZZfpxcqR.hjEtSRNYXbYWw
• Document No. 03 - Framework Agreement and Terms and Conditions

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYn/ODIFaGQoTrt.VZkQb.GuSNR_lvqwMj1K136Yi90k35I
• Document No. 05 - Selectt offer schedule instructions (A2383501)

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYb/0mG0gxewWkt1KnHgWW6lk1rW7Cm6mjwOXrn9TRTW0eo
• Document No. 05b(ii) - Tender Product Listing and Usage - CM_PHR_20_5600_02

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYa/zbn92nWKbL0uYZkg3r8rjTCcXwmsheSFzTBb9JYPlIc
• Document No. 05c - Volume discounts or Additional Products Offer Schedule

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYd/RwQMd_73UU5keMcGVFv6_FDvXNEK.1apWX.h6PvhyEs
• Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS (A2383503)

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYr/8DIrRFEcymJZHQsIrpLdcxFFg7Z2350FKu4mspIthys
• Document No. 05b(v) - Tender Product Listing and Usage - CM_PHR_20_5600_05

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUZ6/CUCVJuU6n12FLGwlcISqFKrzTWDMe2jyNqDG1X_0oLg
• Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_20_5600_01

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYm/GDZnn_oqoIBQ6FdIup9c5fDdYEUwAqMjduIe6kNE6.Y
• Document No. 06 - Form of offer (A2383498)

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYw/j_E2J4vOnBQeNNsbttBHxqHhK.ZqatuVY3tbaji224Q
• Document No. 05b(iii) - Tender Product Listing and Usage - CM_PHR_20_5600_03

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYs/AiccfpedGYGyVYpHKGMcLKFAzZtboPJhk9PLk2MfP74
• Document No. 05b(iv) - Tender Product Listing and Usage - CM_PHR_20_5600_04

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYc/x_5gh0Gd6B4w5WCerv0TJfVqW71OzXwGTeO5tkm3cqs
• Document No.10 - Participating Authorities

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYh/I7dI73faecqBNXfQhsZQP0K.PWsk_bi2ry5rINzmDbI
• Document No. 08 - Confidential information schedule (A2383500)

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYY/u0_lZRQU8xJ3_TTPbqjjGemJjODtxdqbFKcd6hZO_bM
• Document No. 09 - Tender Design and Guidance on completing the ITO

• https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NUYX/9VHNBNV8tu8EKRrF_nBAIUTH_oIVzl9Elf13kVPx3hw
• Document No. 05a( i, ii, iii,iv,v ) CM_PHR_20_5600_00 SELECTT Application

---

About the buyer

Contact name

Giorgie Rushton

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
UK

Email

giorgie.rushton2@nhs.net